CRVO
CRVO
NASDAQ · Biotechnology

Cervomed Inc

$5.31
+0.71 (+15.43%)
As of Feb 8, 2:18 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 8.74M 8.70M 9.10M
Net Income -76,794 -87,592 -73,867
EPS
Profit Margin -0.9% -1.0% -0.8%
Rev Growth +8.7% -7.3% +10.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 14.52M 12.48M 15.52M
Total Equity 19.84M 19.63M 21.56M
D/E Ratio 0.73 0.64 0.72
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -105,264 -93,337 -108,348
Free Cash Flow -51,137 -57,721 -60,543